Multicenter study on costs associated with two surgical procedures: GreenLight XPS 180W versus the gold standard transurethral resection of the prostate - Abstract

OBJECTIVE: To analyze the costs associated with two surgical procedures for lower urinary tract symptoms secondary to benign prostatic hyperplasia: GreenLight XPS 180¦W versus the gold standard transurethral resection of the prostate.

METHODS: A multicenter, retrospective cost study was carried out from the National Health Service perspective, over a 3-month time period. Costs were broken down into pre-surgical, surgical and post-surgical phases. Data were extracted from records of patients operated sequentially, with IPSS=15, Qmax=15mL/seg and a prostate volume of 40-80mL, adding only direct healthcare costs (€, 2013) associated with the procedure and management of complications.

RESULTS: A total of 79 patients sequentially underwent GL XPS (n: 39) or TURP (n: 40) between July and October, 2013. Clinical outcomes were similar (94.9% and 92.5%, GL XPS and TURP, respectively) without significant differences (P=.67). The average direct cost per patient was reduced by €114 in GL XPS versus TURP patients; the cost was higher in the surgical phase with GL XPS (difference: €1,209; P< .001) but was lower in the post-surgical phase (difference: €-1,351; P< .001).

CONCLUSIONS: The GreenLight XPS 180-W laser system is associated with a reduction in costs with respect to transurethral resection of prostate in the surgical treatment of LUTS secondary to PBH. This reduction is due to a shorter inpatient length of stay that offsets the cost of the new technology.

Written by:
Benejam-Gual JM, Sanz-Granda A, Budía A, Extramiana J, Capitán C.   Are you the author?
Servicio de Urología, Hospital de Manacor, Mallorca, España; Proyectos de Farmacoeconomía, Navacerrada, Madrid, España; Servicio de Urología, Hospital de La Fe, Valencia, España; Servicio de Urología, Hospital de Vitoria, Álava, España; Servicio de Urología, Hospital de Alcorcón, Madrid, España.  

Reference: Actas Urol Esp. 2013 Dec 10. pii: S0210-4806(13)00385-9.
doi: 10.1016/j.acuro.2013.10.011


PubMed Abstract
PMID: 24332528

Go "Beyond the Abstract" - Read an article written by the authors for UroToday.com

Article in English, Spanish.

UroToday.com BPH Section